| Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years DC Klonoff, JB Buse, LL Nielsen, X Guan, CL Bowlus, JH Holcombe, ... Current medical research and opinion 24 (1), 275-286, 2008 | 1045 | 2008 |
| Continuous glucose monitoring: roadmap for 21st century diabetes therapy DC Klonoff Diabetes care 28 (5), 1231-1239, 2005 | 994 | 2005 |
| Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States B Bode, V Garrett, J Messler, R McFarland, J Crowe, R Booth, DC Klonoff Journal of diabetes science and technology 14 (4), 813-821, 2020 | 906 | 2020 |
| Threshold-based insulin-pump interruption for reduction of hypoglycemia RM Bergenstal, DC Klonoff, SK Garg, BW Bode, M Meredith, RH Slover, ... New England Journal of Medicine 369 (3), 224-232, 2013 | 792 | 2013 |
| COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. SA Meo, IA Bukhari, J Akram, AS Meo, DC Klonoff European Review for Medical & Pharmacological Sciences 25 (3), 2021 | 648 | 2021 |
| Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) RM Bergenstal, AJ Ahmann, T Bailey, RW Beck, J Bissen, B Buckingham, ... Diabetes technology & therapeutics 15 (3), 198-211, 2013 | 478 | 2013 |
| An economic analysis of interventions for diabetes. DC Klonoff, DM Schwartz Diabetes care 23 (3), 390-404, 2000 | 404 | 2000 |
| COVID-19 pandemic: impact of quarantine on medical students’ mental wellbeing and learning behaviors SA Meo, AA Abukhalaf, AA Alomar, K Sattar, DC Klonoff Pakistan journal of medical sciences 36 (COVID19-S4), S43, 2020 | 393 | 2020 |
| Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open … JB Buse, DC Klonoff, LL Nielsen, X Guan, CL Bowlus, JH Holcombe, ... Clinical therapeutics 29 (1), 139-153, 2007 | 362 | 2007 |
| Noninvasive blood glucose monitoring DC Klonoff Diabetes care 20 (3), 433-437, 1997 | 317 | 1997 |
| Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. SA Meo, AS Meo, FF Al-Jassir, DC Klonoff European Review for Medical & Pharmacological Sciences 25 (24), 2021 | 292 | 2021 |
| Continuous glucose monitoring: an endocrine society clinical practice guideline DC Klonoff, B Buckingham, JS Christiansen, VM Montori, WV Tamborlane, ... The Journal of Clinical Endocrinology & Metabolism 96 (10), 2968-2979, 2011 | 284 | 2011 |
| Continuous glucose monitoring: a review of the technology and clinical use DC Klonoff, D Ahn, A Drincic Diabetes Research and Clinical Practice 133, 178-192, 2017 | 280 | 2017 |
| Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 24-week results from a randomized controlled trial C Mathieu, P Dandona, P Gillard, P Senior, C Hasslacher, E Araki, M Lind, ... Diabetes care 41 (9), 1938-1946, 2018 | 258 | 2018 |
| Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. SA Meo, DC Klonoff, J Akram European Review for Medical & Pharmacological Sciences 24 (8), 2020 | 253 | 2020 |
| Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital GE Umpierrez, DC Klonoff Diabetes care 41 (8), 1579-1589, 2018 | 252 | 2018 |
| Reagent-less whole-blood glucose meter BB Sterling, PC Hartstein, KI Li, MD Agostino, DC Klonoff, RD Gaffney, ... US Patent 6,958,809, 2005 | 231 | 2005 |
| Method and apparatus for improving the accuracy of alternative site analyte concentration measurements P Rule, J Braig, P Hartstein, H Smith, D Klonoff US Patent App. 10/302,071, 2003 | 226 | 2003 |
| The current status of mHealth for diabetes: will it be the next big thing? DC Klonoff Journal of diabetes science and technology 7 (3), 749-758, 2013 | 180 | 2013 |
| Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study S Garg, RL Brazg, TS Bailey, BA Buckingham, RH Slover, DC Klonoff, ... Diabetes technology & therapeutics 14 (3), 205-209, 2012 | 178 | 2012 |
